-
Market Upgrades on 5/10/11- HEOP, KNDL, KWK, LPX, MR, ROSE, SAM, SKS, VIA.B, ALKS, BAP, COLB, CPN, FE, GBL, GTXI
Tuesday, May 10, 2011 - 10:49am | 1309Raymond James upgraded shares of Heritage Oaks Bancorp (HEOP), a holding company for Heritage Oaks Bank (the Bank) from an “underperform” rating to a “market perform” rating. Raymond James upgraded shares of Kendle International (KNDL), a global clinical research organization (CRO) that provides...
-
Market Analysts coverage on 5/10/11- NRG, OLP, RIO, TAL, TRGP, VIVO, VRX, VVC, AAUKY, BHP, BOBE, CEPH, CSCO, CZZ, GPK, MDVN, NGLS, NNA
Tuesday, May 10, 2011 - 10:14am | 1311Dahlman Rose analysts initiated coverage on shares of NRG Energy Inc. (NRG),a wholesale power generation company. They set a “buy” rating and a $29.00 price target on the stock. Compass Point analysts initiated coverage on shares of a self-administered and self-managed real estate investment...
-
Thermo Fisher Scientific Provides Update on Acquisition of Dionex Corporation, Sees Consummating Offer May 13 (TMO, DNEX)
Tuesday, May 10, 2011 - 8:46am | 142Thermo Fisher Scientific (NYSE: TMO), the world leader in serving science, is confident in being able to secure all necessary outstanding regulatory and antitrust approvals in connection with its previously announced tender offer to acquire all of the outstanding shares of Dionex Corporation (...
-
UPDATE: J.P. Morgan Raising Price Target On Luminex (LMNX)
Tuesday, May 10, 2011 - 8:00am | 154J.P. Morgan Chase & Co. is raising its price target on shares of Luminex (NASDAQ: LMNX) to $18 from $17, and it has a Neutral rating on shares after it reported earnings. In a note to investors, J.P. Morgan writes, "Luminex delivered strong Q1 results, with revenues and EPS coming in above...
-
Jefferies Raises PT On LMNX To $17
Tuesday, May 10, 2011 - 7:14am | 125Jefferies has raised its price target on Luminex Corp. (NASDAQ: LMNX) from $16 to $17 in light of 1Q11 results. Says Jefferies, in its report, “LMNX's 1Q11 EPS of $0.11 was $0.05 ahead of consensus on stronger revenue growth and profit trends. We are raising our 2011 EPS forecast to $0.30 (from $0...
-
Jefferies Lowers PT On Luminex To $16
Tuesday, May 10, 2011 - 6:10am | 26Jefferies & Company has lowered the price target on Luminex (NASDAQ: LMNX) from $17 to $16 and maintains its Hold rating.
-
Reports EPS of $0.11, May Not Be Comparable to $0.06 Estimate; Revenues $43.28M vs. $39.90M Estimate
Monday, May 9, 2011 - 3:04pm | 26Luminex Corporation (NASDAQ: LMNX) Reports EPS of $0.11 May Not Be Comparable to $0.06 Estimate; Revenues $43.28M vs. $39.90M Estimate
-
Calls Purchased on Sequenom, Inc. (SQNM)
Monday, May 9, 2011 - 10:41am | 144Shares of Sequenom, Inc. (NASDAQ: SQNM) are higher on the session by 3.74%, currently trading at $8.04. The stock has been moving largely higher over the past three months and is currently trading above the 50-day and 200-day moving averages. Options traders are buying calls on the name today. A...
-
Affymetrix Achieves First FDA Clearance of Microarray-Based Gene Profiling Reagents (AFFX)
Monday, May 9, 2011 - 9:06am | 121Affymetrix, Inc. (NASDAQ: AFFX) today announced that the U.S. Food and Drug Administration has cleared the addition of new gene expression reagents as accessories to its GeneChip Microarray Instrument System for in vitro diagnostic use, making Affymetrix the first in the industry to provide a...
-
Benzinga's Top Pre-Market NASDAQ Gainers (ONTY, BSFT, MNKD, SQNM)
Monday, May 9, 2011 - 8:20am | 131Oncothyreon Inc (NASDAQ: ONTY) shares surged 11.63% to $4.99 in the pre-market session. ONTY reported its Q1 net loss from operations at $5.9 million, versus $5.4 million, in the year-ago quarter. BroadSoft Inc (NASDAQ: BSFT) shares advanced 8.31% to $46.77 in the pre-market session. BSFT reported...
-
Astellas and Medivation Announce Initiation of Phase 2 Clinical (MDVN)
Monday, May 9, 2011 - 8:04am | 92Astellas Pharma Inc. and Medivation, Inc. (NASDAQ: MDVN) today announced treatment of the first patient in the second new Phase 2 clinical trial of the investigational drug MDV3100, a triple-acting oral androgen receptor antagonist. This trial is evaluating MDV3100 monotherapy as the first hormonal...
-
Top Chemical Manufacturing Stocks pick to buy- FSI, VHI, SMG, LXU, TNH, SHI, BAK, CF, RTK, GRA, NANX…
Monday, May 9, 2011 - 4:45am | 1808Flexible Solutions International Inc. (AMEX:FSI) is trading at a price of $1.85,a dramatic change of 0.14 with % change of 8.19 from its previous day's close. Currently, the company has a Market capitalization (total value of a company in the stock market) of approximately 24.36M. Flexible...
-
Bioanalytical Systems, Inc. to Raise Approximately $5.5 Million in Registered Securities Offering (BASI)
Friday, May 6, 2011 - 9:42am | 88(NASDAQ: BASI) Bioanalytical Systems today announced that it has entered into definitive agreements with investors for a public offering of 5,506 units at a price of $1,000 per unit to the public with each unit consisting of one 6% Series A Convertible Preferred Share which is convertible into 500...
-
Jefferies Comments on Sequenom (SQNM)
Friday, May 6, 2011 - 9:15am | 132Jefferies & Company released a report on Sequenom (NASDAQ: SQNM) earlier. In the report, Jefferies raised revenue forecasts for the company, but did not alter their price target. Jefferies states, “SQNM's 1Q11 revenue of $13.5M was +6% above consensus. We are raising our 2011 and 2012 revenue...
-
Top Scientific & Technical Equipment Stock Picks to buy on 5/6/11- OSIS, FLDM, CALP, CBMX, IRIS, ZIGO, TRMB, SMIT, MEAD, OYOG
Friday, May 6, 2011 - 6:24am | 2070OSI Systems Inc. (NASDAQ:OSIS) is trading at a price of $37.57, a dramatic change of +1.06 with Change% of 2.90 from its previous day's close. Currently, the company has a Market capitalization (total value of a company in the stock market) of approximately 715.78M. OSI Systems announced that its...